NLS Pharmaceutics AG
NASDAQ:NLSP
NLS Pharmaceutics AG
Revenue
NLS Pharmaceutics AG
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Novartis AG
SIX:NOVN
|
Revenue
$58.8B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
Roche Holding AG
SIX:ROG
|
Revenue
CHf58.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Revenue
$9.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is NLS Pharmaceutics AG's Revenue?
Revenue
0
USD
Based on the financial report for Dec 31, 2022, NLS Pharmaceutics AG's Revenue amounts to 0 USD.